JP2023512450A5 - - Google Patents
Info
- Publication number
- JP2023512450A5 JP2023512450A5 JP2022542652A JP2022542652A JP2023512450A5 JP 2023512450 A5 JP2023512450 A5 JP 2023512450A5 JP 2022542652 A JP2022542652 A JP 2022542652A JP 2022542652 A JP2022542652 A JP 2022542652A JP 2023512450 A5 JP2023512450 A5 JP 2023512450A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- amino acid
- heavy chain
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062960663P | 2020-01-13 | 2020-01-13 | |
| US62/960,663 | 2020-01-13 | ||
| US202063070728P | 2020-08-26 | 2020-08-26 | |
| US63/070,728 | 2020-08-26 | ||
| US202063091717P | 2020-10-14 | 2020-10-14 | |
| US63/091,717 | 2020-10-14 | ||
| PCT/US2021/013200 WO2021146256A1 (en) | 2020-01-13 | 2021-01-13 | Anti-trem2 antibodies and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512450A JP2023512450A (ja) | 2023-03-27 |
| JP2023512450A5 true JP2023512450A5 (cg-RX-API-DMAC7.html) | 2024-01-22 |
| JP7870250B2 JP7870250B2 (ja) | 2026-06-04 |
Family
ID=74587108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542652A Active JP7870250B2 (ja) | 2020-01-13 | 2021-01-13 | 抗trem2抗体及びその使用方法 |
Country Status (17)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS63818B1 (sr) | 2017-02-17 | 2023-01-31 | Denali Therapeutics Inc | Konstruisani polipeptidi za vezivanje za receptor transferina |
| BR112020005271A2 (pt) | 2017-10-02 | 2020-09-15 | Denali Therapeutics Inc. | proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica |
| JP7543290B2 (ja) | 2019-02-20 | 2024-09-02 | デナリ セラピューティクス インコーポレイテッド | 抗trem2抗体及びその使用方法 |
| BR112022012230A2 (pt) | 2019-12-23 | 2022-08-30 | Denali Therapeutics Inc | Variantes de progranulina |
| CR20230178A (es) | 2020-10-14 | 2023-07-26 | Denali Therapeutics Inc | Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas |
| IL311003A (en) | 2021-08-25 | 2024-04-01 | Denali Therapeutics Inc | Anti-2HER antibodies and methods of using them |
| MX2024010324A (es) | 2022-02-23 | 2024-08-30 | Alector Llc | Metodos de uso de anticuerpos anti-trem2. |
| EP4499693A1 (en) | 2022-03-28 | 2025-02-05 | Denali Therapeutics Inc. | Monovalent anti-trem2 binding molecules and methods of use thereof |
| EP4499695A1 (en) | 2022-03-28 | 2025-02-05 | Denali Therapeutics Inc. | Methods for treating brain glucose hypometabolism |
| WO2024253424A1 (ko) * | 2023-06-09 | 2024-12-12 | 재단법인대구경북과학기술원 | 인간 trem2 단백질에 특이적으로 결합하는 인간화 항체 및 이의 용도 |
| WO2024253420A1 (ko) * | 2023-06-09 | 2024-12-12 | 재단법인대구경북과학기술원 | 인간 trem2 단백질에 특이적으로 결합하는 인간 항체 및 이의 용도 |
| KR20260044219A (ko) | 2023-07-21 | 2026-04-01 | 매로우 테라퓨틱스, 인크. | 조혈 세포 표적화 접합체 및 관련 방법 |
| WO2026062582A1 (en) * | 2024-09-20 | 2026-03-26 | Novartis Ag | Methods of treatment using anti-trem2 antibodies |
| WO2026062585A1 (en) * | 2024-09-20 | 2026-03-26 | Novartis Ag | Methods of treatment using anti-trem2 antibodies |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10087408B2 (en) | 2010-07-07 | 2018-10-02 | The University Of British Columbia | System and method for microfluidic cell culture |
| US9188593B2 (en) | 2010-07-16 | 2015-11-17 | The University Of British Columbia | Methods for assaying cellular binding interactions |
| EA201790342A1 (ru) * | 2014-08-08 | 2017-07-31 | ЭЛЕКТОР ЭлЭлСи | Антитела к trem2 и способы их применения |
| JP7725185B2 (ja) * | 2015-10-06 | 2025-08-19 | アレクトル エルエルシー | 抗trem2抗体及びその使用方法 |
| RS63818B1 (sr) | 2017-02-17 | 2023-01-31 | Denali Therapeutics Inc | Konstruisani polipeptidi za vezivanje za receptor transferina |
| EP4628586A3 (en) | 2017-02-17 | 2026-01-14 | Denali Therapeutics Inc. | Transferrin receptor transgenic models |
| JOP20190248A1 (ar) * | 2017-04-21 | 2019-10-20 | Amgen Inc | بروتينات ربط مولد ضد trem2 واستخداماته |
| HUE062436T2 (hu) | 2017-08-03 | 2023-11-28 | Alector Llc | Anti-trem2 antitestek és alkalmazási módszereik |
| WO2019055841A1 (en) * | 2017-09-14 | 2019-03-21 | Denali Therapeutics Inc. | ANTI-TREM2 ANTIBODIES AND METHODS OF USE |
| CN113302206A (zh) | 2018-11-26 | 2021-08-24 | 戴纳立制药公司 | 治疗脂质代谢失调的方法 |
| JP7543290B2 (ja) * | 2019-02-20 | 2024-09-02 | デナリ セラピューティクス インコーポレイテッド | 抗trem2抗体及びその使用方法 |
-
2021
- 2021-01-13 WO PCT/US2021/013200 patent/WO2021146256A1/en not_active Ceased
- 2021-01-13 JP JP2022542652A patent/JP7870250B2/ja active Active
- 2021-01-13 KR KR1020227025637A patent/KR20220131246A/ko active Pending
- 2021-01-13 CN CN202180008986.5A patent/CN115279790A/zh active Pending
- 2021-01-13 PE PE2022001437A patent/PE20221465A1/es unknown
- 2021-01-13 IL IL294655A patent/IL294655A/en unknown
- 2021-01-13 EP EP21704639.0A patent/EP4090682A1/en active Pending
- 2021-01-13 AU AU2021208482A patent/AU2021208482B2/en active Active
- 2021-01-13 MX MX2022008582A patent/MX2022008582A/es unknown
- 2021-01-13 PH PH1/2022/551650A patent/PH12022551650A1/en unknown
- 2021-01-13 TW TW110101213A patent/TWI890727B/zh active
- 2021-01-13 CA CA3166385A patent/CA3166385A1/en active Pending
- 2021-01-13 BR BR112022013756A patent/BR112022013756A2/pt unknown
- 2021-09-17 US US17/478,587 patent/US20220177576A1/en not_active Abandoned
-
2022
- 2022-07-12 CL CL2022001886A patent/CL2022001886A1/es unknown
- 2022-07-12 EC ECSENADI202254464A patent/ECSP22054464A/es unknown
- 2022-07-12 CO CONC2022/0009744A patent/CO2022009744A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022520868A5 (cg-RX-API-DMAC7.html) | ||
| JP2021527656A5 (cg-RX-API-DMAC7.html) | ||
| JP7046804B2 (ja) | 改良された血清アルブミン結合剤 | |
| US20200216522A1 (en) | Anti-tau antibodies and methods of use thereof | |
| JP2016147902A5 (cg-RX-API-DMAC7.html) | ||
| JP2020534277A5 (cg-RX-API-DMAC7.html) | ||
| JP2021533779A5 (cg-RX-API-DMAC7.html) | ||
| JP7772715B2 (ja) | 治療用musk抗体 | |
| RU2008129787A (ru) | Фармацевтические композиции с устойчивостью к растворимому сеа | |
| JP2021534220A5 (cg-RX-API-DMAC7.html) | ||
| HUE025684T2 (en) | Immunotherapy regimen dependent on ApoE status | |
| CN115298214A (zh) | 用于靶向淀粉样蛋白沉积物的经修饰的免疫球蛋白 | |
| HRP20192267T1 (hr) | Terapeutski agens ili profilaktički agens za demenciju | |
| JP2022529344A (ja) | 治療及び診断のための新規分子 | |
| JP7797203B2 (ja) | 抗gal9免疫阻害性結合分子 | |
| US20230074436A1 (en) | Anti-alpha-synuclein antibodies and methods of use thereof | |
| TW202219068A (zh) | 包含il—12及抗fap抗體的融合蛋白及其用途 | |
| CN116368153A (zh) | Zip12抗体 | |
| US20260109761A1 (en) | Zip12 antibody | |
| KR102862890B1 (ko) | Aimp2 및/또는 aimp2 응집체에 특이적으로 결합하는 항체 | |
| WO2022103660A1 (en) | Bifunctional antagonists of activin/tgf-beta and rankl and uses thereof | |
| JP2024543942A5 (cg-RX-API-DMAC7.html) |